Infinium Pharmachem

₹217 0 | 0%

WEBSITE BSE:0 NSE : 17 May, 00:00

Market Cap ₹302 Cr.

Stock P/E 0.0

P/B 5.5

Current Price ₹217

Book Value ₹ 39.4

Face Value 10

52W High ₹315.7

Dividend Yield 0%

52W Low ₹ 130

Edit Ratio

Infinium Pharmachem Research see more...

Overview Inc. Year: 2003Industry: Chemicals

Infinium Pharmachem Ltd is a dynamic and innovative company operating in the pharmaceutical and chemical industry. With a commitment to excellence and a focus on customer satisfaction, Infinium Pharmachem has established itself as a trusted provider of high-quality products and services. The company specializes in the manufacturing and distribution of a wide range of pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and fine chemicals. Leveraging state-of-the-art technology and a team of experienced professionals, Infinium Pharmachem strives to meet the evolving needs of its clients. Infinium Pharmachem is dedicated to maintaining the highest standards of quality, safety, and environmental sustainability in its operations. The company adheres to stringent regulatory guidelines and continuously invests in research and development to deliver innovative solutions and products. With a global presence and a strong network of partners, Infinium Pharmachem aims to contribute to the advancement of the pharmaceutical and chemical sectors, while fostering long-term relationships with its customers and stakeholders.

Infinium Pharmachem Share Price

New

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

Infinium Pharmachem Quarterly Results

#(Fig in Cr.)
Net Sales
Other Income
Total Income
Total Expenditure
Operating Profit
Interest
Depreciation
Exceptional Income / Expenses
Profit Before Tax
Provision for Tax
Profit After Tax
Adjustments
Profit After Adjustments
Adjusted Earnings Per Share

Infinium Pharmachem Profit & Loss

#(Fig in Cr.)	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Net Sales	39	71	99	114
Other Income	1	1	1	1
Total Income	39	71	100	116
Total Expenditure	36	66	89	98
Operating Profit	3	6	11	17
Interest	1	1	2	3
Depreciation	1	1	1	1
Exceptional Income / Expenses	0	0	0	0
Profit Before Tax	1	4	9	13
Provision for Tax	0	1	2	3
Profit After Tax	1	3	7	10
Adjustments	0	-0	-1	-0
Profit After Adjustments	1	3	6	9
Adjusted Earnings Per Share	0.9	2.7	6	9.3

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	15%	43%	0%	0%
Operating Profit CAGR	55%	78%	0%	0%
PAT CAGR	43%	115%	0%	0%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	62%	NA%	NA%	NA%
ROE Average	55%	57%	48%	48%
ROCE Average	37%	36%	32%	32%

Infinium Pharmachem Balance Sheet

#(Fig in Cr.)	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Shareholder's Funds	4	7	13	23
Minority's Interest	0	0	1	1
Borrowings	6	6	14	10
Other Non-Current Liabilities	-0	-0	-0	-0
Total Current Liabilities	12	21	31	37
Total Liabilities	22	34	59	71
Fixed Assets	4	5	4	19
Other Non-Current Assets	0	4	11	0
Total Current Assets	18	25	44	51
Total Assets	22	34	59	71

Infinium Pharmachem Cash Flow

#(Fig in Cr.)	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Opening Cash & Cash Equivalents	0	1	2	5
Cash Flow from Operating Activities	3	7	12	9
Cash Flow from Investing Activities	-1	-5	-7	-5
Cash Flow from Financing Activities	-1	-1	-2	-3
Net Cash Inflow / Outflow	1	1	3	1
Closing Cash & Cash Equivalent	1	2	5	6

Infinium Pharmachem Ratios

#	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Earnings Per Share (Rs)	0.92	2.68	6.01	9.33
CEPS(Rs)	1.43	3.33	7.2	10.97
DPS(Rs)	0	0	0	0
Book NAV/Share(Rs)	4.18	6.91	12.89	22.19
Core EBITDA Margin(%)	6.39	7.02	10.12	14.05
EBIT Margin(%)	6.38	6.98	10.43	14.06
Pre Tax Margin(%)	3.19	5.34	8.71	11.34
PAT Margin (%)	2.23	3.87	6.75	8.59
Cash Profit Margin (%)	3.73	4.79	7.38	9.77
ROA(%)	3.87	9.66	14.37	15.16
ROE(%)	20.43	48.44	66.44	55.06
ROCE(%)	18.89	32.14	38.88	36.74
Receivable days	74.56	50.25	49.49	49.25
Inventory Days	64.85	42.14	47.4	57.64
Payable days	82.28	62.12	28.25	0
PER(x)	0	0	0	0
Price/Book(x)	0	0	0	0
Dividend Yield(%)	0	0	0	0
EV/Net Sales(x)	0.23	0.14	0.18	0.25
EV/Core EBITDA(x)	2.95	1.71	1.65	1.63
Net Sales Growth(%)	0	81.58	40.53	15.24
EBIT Growth(%)	0	98.82	109.84	55.38
PAT Growth(%)	0	214.58	144.91	46.84
EPS Growth(%)	0	191.73	124.1	55.41
Debt/Equity(x)	2.09	1.5	1.72	1.3
Current Ratio(x)	1.46	1.2	1.39	1.4
Quick Ratio(x)	0.91	0.76	0.87	0.86
Interest Cover(x)	2	4.26	6.07	5.17
Total Debt/Mcap(x)	0	0	0	0

Infinium Pharmachem Shareholding Pattern

#	Sep 2023	Mar 2024
Promoter	73.05	73.05
FII	0	0
DII	0	0
Public	26.95	26.95
Others	0	0
Total	100	100

#	Sep 2023	Mar 2024
Promoter	1.02	1.02
FII	0	0
DII	0	0
Public	0.38	0.38
Others	0	0
Total	1.39	1.39

Pros

Company has a good return on equity (ROE) track record: 3 Years ROE 57%
Debtor days have improved from 28.25 to 0days.
Company has reduced debt.

Cons

Stock is trading at 5.5 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.